×
About 36,248 results

ALLMedicine™ Type 1 Diabetes Center

Research & Reviews  11,934 results

Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
https://doi.org/10.1371/journal.pone.0254859
PloS One; Stougaard EB, Winther SA et. al.

Jul 31st, 2021 - Glycocalyx lines the inner surface of the capillary endothelium. Capillaroscopy enables visualization of the sublingual capillaries and measurement of the Perfused Boundary Region (PBR) as an estimate of the glycocalyx. Novel software enables asse...

TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Au...
https://doi.org/10.2337/dc21-0531
Diabetes Care; Redondo MJ, Warnock MV et. al.

Jul 31st, 2021 - We aimed to test whether type 2 diabetes (T2D)-associated TCF7L2 genetic variants affect insulin sensitivity or secretion in autoantibody-positive relatives at risk for type 1 diabetes (T1D). We studied autoantibody-positive TrialNet Pathway to Pr...

Is there an optimal approach to elective stabilisation of glycaemic control in children...
https://doi.org/10.1111/jpc.15667
Journal of Paediatrics and Child Health; Atlas G, O'Connell MA et. al.

Jul 30th, 2021 - To investigate the effectiveness of inpatient and outpatient interventions in attaining improved glycaemic control in children/adolescents with type 1 diabetes mellitus and persistently high/deteriorating HbA1c. A retrospective study at a tertiary...

Baseline extended zone retinal vascular calibers associate with sensory nerve abnormali...
https://doi.org/10.1111/dme.14662
Diabetic Medicine : a Journal of the British Diabetic Ass... Velayutham V, Benitez-Aguirre PZ et. al.

Jul 30th, 2021 - The relationship between retinal vascular calibers (RVCs) and diabetic neuropathy is unclear. We investigated associations between RVCs and sensory nerve abnormality in adolescents with type 1 diabetes. In a prospective longitudinal study of 889 a...

Psychosocial factors associated with repeat diabetic ketoacidosis in people living with...
https://doi.org/10.1111/dme.14663
Diabetic Medicine : a Journal of the British Diabetic Ass... Allcock B, Stewart R et. al.

Jul 30th, 2021 - To systematically review the literature concerning the psychosocial factors associated with repeat diabetic ketoacidosis for people living with type 1 diabetes. PsycInfo, Web of Science, CINAHL, PubMed and ASSIA were searched according to a regist...

see more →

Guidelines  15 results

Glucose management for exercise using continuous glucose monitoring (CGM) and intermitt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702152
Pediatric Diabetes; Moser O, Riddell MC et. al.

Oct 14th, 2020 - Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and d...

Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438223
Diabetes Research and Clinical Practice; d'Annunzio G, Maffeis C et. al.

Aug 23rd, 2020 - Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society...

Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diab...
https://doi.org/10.1016/j.numecd.2020.06.006
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.

Aug 11th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Perioperative Management of Pediatric Patients With Type 1 Diabetes Mellitus, Updated R...
https://doi.org/10.1213/ANE.0000000000004491
Anesthesia and Analgesia; Martin LD, Hoagland MA et. al.

Nov 7th, 2019 - Approximately 1 of every 300 children in the United States has type 1 diabetes mellitus (T1D), and these patients may require anesthetics for a variety of procedures. Perioperative coordination is complex, and attention to perioperative fasting, a...

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

see more →

Drugs  351 results see all →

Clinicaltrials.gov  750 results

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
https://clinicaltrials.gov/ct2/show/NCT00419562

May 7th, 2020 - Eligible participants will be randomized to receive either oral insulin (7.5 mg of recombinant human insulin crystals) or placebo daily. All participants randomized into this study will be seen at a study site for a follow-up evaluation, three and...

Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects
https://clinicaltrials.gov/ct2/show/NCT00529399

May 7th, 2020 - Type 1 diabetes (T1D) is an autoimmune disease. This means that the immune system (the part of the body which helps fight infections) mistakenly attacks and destroys the cells that produce insulin (islet cells found in the pancreas called islet ce...

Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
https://clinicaltrials.gov/ct2/show/NCT00505375

May 6th, 2020 - Type 1 diabetes mellitus (T1DM) is a T-cell mediated autoimmune disease in which insulin-producing beta cells are completely or near completely destroyed resulting in life-long dependence on exogenous insulin. CTLA4-Ig (Abatacept) inhibits a cruci...

New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT00100178

May 5th, 2020 - Design of Study: The study is a multi-center, three-arm, randomized, double-masked, placebo-controlled clinical trial. Comparisons will be made among the three groups, which are: Mycophenolate mofetil active drug with Daclizumab (DZB) placebo IV M...

Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT03377699

May 5th, 2020 - The investigators are doing this study to see the effect of insulin degludec in pregnant women with type 1 diabetes, and if it is safe to use. In this study the medicine insulin degludec is compared to another medicine called insulin detemir. Part...

see more →

News  1,422 results

Cancer Drug May Slow Course of Type 1 Diabetes
https://www.medscape.com/viewarticle/954931

Jul 19th, 2021 - NEW YORK (Reuters Health) - The tyrosine-kinase inhibitor imatinib used to treat chronic myeloid leukemia and other cancers may help preserve beta-cell function in people with recently diagnosed type-1 diabetes, according to findings from a phase-...

FDA Rejects Teplizumab for Type 1 Diabetes Delay
https://www.medscape.com/viewarticle/954307

Jul 7th, 2021 - The US Food and Drug Administration (FDA) has declined to approve the anti-CD3 monoclonal antibody teplizumab (Tzield, Provention Bio) for the delay of type 1 diabetes in at-risk individuals, despite narrow endorsement in a 10-7 vote in favor of a...

Nocturnal Hypoglycemia Halved With Insulin Degludec vs Glargine, Confirms Study in Type 1 Diabetes
https://www.medscape.com/viewarticle/954268

Jul 6th, 2021 - Patients with type 1 diabetes who used insulin degludec as their basal insulin had fewer than half the number of nocturnal hypoglycemia events, compared with patients who used insulin glargine U100, in a head-to-head crossover study with 51 patien...

Insulin-Pramlintide Combo Improves Type 1 Diabetes Control
https://www.medscape.com/viewarticle/954243

Jul 6th, 2021 - A novel investigational coformulation of prandial insulin and pramlintide improves blood glucose control and reduces body weight in people with type 1 diabetes, early research suggests. The injectable product combines a novel human prandial (pre-m...

ADA/EASD Draft Guidance Aims to Bring Adults With Type 1 Diabetes Out of Shadows
https://www.medscape.com/viewarticle/954069

Jul 1st, 2021 - A new draft consensus statement from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) addresses diagnosis and management of type 1 diabetes in adults.   The impetus for the document comes from t...

see more →

Patient Education  27 results see all →